PGNAX | RSNRX | PGNAX / RSNRX | |
Total Expense Ratio | 1.26 | 1.48 | 85% |
Annual Report Gross Expense Ratio | 1.26 | 1.54 | 82% |
Fund Existence | 35 years | 30 years | - |
Gain YTD | 12.761 | 24.684 | 52% |
Front Load | 6% | 6% | 96% |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 697M | 383M | 182% |
Annual Yield % from dividends | 0.87 | 1.36 | 64% |
Returns for 1 year | 1.03 | 28.33 | 4% |
Returns for 3 years | 25.83 | 44.89 | 58% |
Returns for 5 years | 144.32 | 403.60 | 36% |
Returns for 10 years | 70.30 | 74.47 | 94% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EDC | 40.36 | 0.52 | +1.31% |
Direxion Daily MSCI Em Mkts Bull 3X ETF | |||
CPSJ | 26.15 | 0.03 | +0.11% |
Calamos S&P 500 Str Alt Prt ETF-Jul | |||
ICLO | 25.63 | 0.02 | +0.08% |
Invesco AAA CLO Floating Rate Note ETF | |||
HELX | 28.05 | N/A | N/A |
Franklin Genomic Advancements ETF | |||
ZROZ | 65.35 | -0.63 | -0.95% |
PIMCO 25+ Year Zero Coupon US Trs ETF |